Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study

por Mark, M., Rusakiewicz, S., Früh, M., Hayoz, S., Grosso, F., Pless, M., Zucali, P., Ceresoli, G.L., Maconi, A., Schneider, M., Froesch, P., Tarussio, D., Benedetti, F., Dagher, J., Kandalaft, L., von Moos, R., Tissot-Renaud, S., Schmid, S., Metaxas, Y.
Publicado 2022